Pricing Log in Create free account
Friday 6 November 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

BIO Healthcare Medical Devices

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue
+0.52%
EPS
+234.9%
Free cash flow
+8.07%
Total debt
+0.11%

Quarter to September 2026, against a year earlier

382.95 13.95 +3.78%
Market cap
$9.9B
P/E
9.7×
Fwd P/E
44.7×
Dividend yield
—
F-score
5/9
Altman Z
3.20
Beneish M
−2.29
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bio-Rad Laboratories, Inc. (BIO) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Bio-Rad Laboratories, Inc. (BIO) trades at a price to free cash flow of 30.0×. Over the past ten years it has ranged from 0.0× (March 2018) to 562× (June 2017); the current reading is higher than 24% of that period. That is in line with the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 21.9× (30.99%)
FY2024 31.8× (26.90%)
FY2023 43.5× (71.05%)
FY2022 150× 259.11%
FY2021 41.8× 15.60%
FY2020 36.2× 20.61%
FY2019 30.0× (30.77%)
FY2018 43.3× —
FY2017 0.0× —
FY2016 72.0× 29.65%

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 30.6× 38.35%
Jun 2026 22.1× 5.77%
Mar 2026 20.9× (4.65%)
Dec 2025 21.9× (1.55%)
43 more quarters

Against its own ten years

Low 0.0× High 562×
Ten-year median 40.3×
Current reading's percentile 24

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 7.1×
GMED Globus Medical, Inc. compare 14.5×
BIO Bio-Rad Laboratories, Inc. 30.0×
BIO.B Bio-Rad Laboratories, Inc. compare 30.7×
BRKR Bruker Corporation compare 32.9×
PODD Insulet Corporation compare 46.4×
PEN Penumbra, Inc. compare 63.1×
TXG 10x Genomics compare 63.3×
GKOS Glaukos Corporation compare 360×
Medical Devices industry median 28.8×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on BIO